Advertisement

Topics

Johnson & Johnson says drugs sales up 4.1 percent in Q1, bolstered by Stelara, Darzalex https://www.firstwordpharma.com/node/1635450?tsid=28®ion_id=6 …

10:32 EDT 16 Apr 2019 | FirstWord Pharma

Johnson & Johnson says drugs sales up 4.1 percent in Q1, bolstered by Stelara, Darzalex https://www.firstwordpharma.com/node/1635450?tsid=28&region_id=6 …

Original Article: Johnson & Johnson says drugs sales up 4.1 percent in Q1, bolstered by Stelara, Darzalex https://www.firstwordpharma.com/node/1635450?tsid=28®ion_id=6 …

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson says drugs sales up 4.1 percent in Q1, bolstered by Stelara, Darzalex https://www.firstwordpharma.com/node/1635450?tsid=28®ion_id=6 …"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...